Laboratory findings and biomarkers in Long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges

D Tsilingiris, NG Vallianou, I Karampela… - International Journal of …, 2023 - mdpi.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes

Y Zhang, V Bharathi, T Dokoshi… - Proceedings of the …, 2024 - National Acad Sciences
It is unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
leads to the strong but ineffective inflammatory response that characterizes severe …

[HTML][HTML] Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections

AH de Nooijer, P Pickkers, MG Netea, M Kox - Journal of Critical Care, 2023 - Elsevier
Mortality in acute infections is mostly associated with sepsis, defined as 'life-threatening
organ dysfunction caused by a dysregulated host response to infection'. It remains …

Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection

NJ Silverstein, Y Wang, Z Manickas-Hill, C Carbone… - Elife, 2022 - elifesciences.org
Background: Risk of severe COVID-19 increases with age, is greater in males, and is
associated with lymphopenia, but not with higher burden of SARS-CoV-2. It is unknown …

Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline …

A Syenina, ES Gan, JZN Toh, R de Alwis, LZ Lin… - PLoS …, 2022 - journals.plos.org
Ensuring high vaccination and even booster vaccination coverage is critical in preventing
severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines …

Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19

ED Hottz, R Martins-Gonçalves, L Palhinha… - Blood …, 2022 - ashpublications.org
Accumulating evidence into the pathogenesis of COVID-19 highlights a hypercoagulability
state with high risk of life-threatening thromboembolic complications. However, the …

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

FG Özbay Kurt, A Lepper, C Gerhards… - Frontiers in …, 2022 - frontiersin.org
A gradual decay in humoral and cellular immune responses over time upon SAR1S-CoV-2
vaccination may cause a lack of protective immunity. We conducted a longitudinal analysis …

Fatigue in the COVID-19 pandemic

D Azzolino, M Cesari - The Lancet Healthy Longevity, 2022 - thelancet.com
Beyond diseases and syndromes, there are some other conditions, such as fatigue, which
are frequently reported by older people and represent unmet clinical needs. In particular …

T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19

F Venet, M Gossez, F Bidar, M Bodinier… - …, 2022 - thelancet.com
Background In critically ill COVID-19 patients, the initial response to SARS-CoV-2 infection
is characterized by major immune dysfunctions. The capacity of these severe patients to …

Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections

Q Fan, J Shi, Y Yang, G Tang, M Jiang, J Li… - Nature …, 2022 - nature.com
Despite timely immunization programs, and efficacious vaccines conveying protection
against SARS-CoV-2 infection, breakthrough infections in vaccinated individuals have been …